Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results.
Total sales increased 10.1% year-over-year to $11.3 billion. On an organic basis, revenues grew 14.3%.
GAAP net earnings rose nearly 70% YoY to $2 billion and EPS rose nearly 73% to $1.14. Adjusted EPS grew 22.2% to $1.43.
For FY2022, GAAP EPS is expected to be at least $3.50 and adjusted EPS is expected to be at least $4.90.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
AAPL Earnings: Apple’s Q2 sales and profit beat estimates; iPhone sales down 10%
Apple Inc. (NASDAQ: AAPL) on Thursday reported better-than-expected profit and revenue for the second quarter of 2024. There was a 10% decrease in iPhone sales. The gadget giant reported revenues
Shopify (SHOP) is all set to report Q1 2024 results. Here’s what to expect
Over the years, Shopify Inc. (NYSE: SHOP) has steadily expanded its footprint in the online retail market through constant innovation, like the recent launch of a mobile POS device for
eBay (EBAY): A look at how the ecommerce company fared in Q1 2024
Shares of eBay Inc. (NASDAQ: EBAY) were down over 2% on Thursday. The company reported its earnings results for the first quarter of 2024 a day ago, with revenue and